awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36973229-7ED635B0-4F62-497A-9E1A-B9C710B63C11
Q36973229-7ED635B0-4F62-497A-9E1A-B9C710B63C11
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36973229-7ED635B0-4F62-497A-9E1A-B9C710B63C11
A randomized study of melphalan 200 mg/m(2) vs 280 mg/m(2) as a preparative regimen for patients with multiple myeloma undergoing auto-SCT
P2860
Q36973229-7ED635B0-4F62-497A-9E1A-B9C710B63C11
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36973229-7ED635B0-4F62-497A-9E1A-B9C710B63C11
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d0964b5beb3ecd53fbae3dca07ea95a8aed9aee8
P2860
A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.